Hiroki Suekane
Kurume, 8300011, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Dramatic reversal of severe left ventricular dysfunction after percutaneous nephrostomy in a patient with bilateral impacted ureteral stones.
Journal: Journal of surgical case reports
Published: December 19, 2025
Permanent Prostate Brachytherapy Placement: Imaging Assessment of Seed Positioning, Spacer Use, and Complications.
Journal: Radiographics : a review publication of the Radiological Society of North America, Inc
Published: November 26, 2025
Effects of Three Different Ureteral Stents on Stent-Related Symptoms in Patients Undergoing Ureteroscopic Lithotripsy: Assessment Using the Ureteral Stent Symptoms Questionnaire.
Journal: Journal of endourology
Published: November 06, 2025
Analysis of Early Progression in Advanced Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab.
Journal: Cancer diagnosis & prognosis
Published: March 04, 2025
EFFICACY AND SAFETY OF ENFORTUMAB VEDOTIN IN ADVANCED UROTHELIAL CARCINOMA TREATMENT: AN INITIAL EXPERIENCE IN A SINGLE INSTITUTION
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
Published: January 19, 2025
Prognostic Stratification Using Early Prostate-specific Antigen Kinetics in Men With Metastatic Hormone-sensitive Prostate Cancer.
Journal: Anticancer research
Published: December 14, 2024
A prospective comparison of implant quality between suture-coated seeds and uncoated seeds in prostate cancer brachytherapy.
Journal: Journal of contemporary brachytherapy
Published: May 15, 2024
Soluble Immune Checkpoint Molecules as Predictors of Efficacy in Immuno-Oncology Combination Therapy in Advanced Renal Cell Carcinoma.
Journal: Current oncology (Toronto, Ont.)
Published: March 01, 2024
Prognostic Value of Absolute Lymphocyte Count in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab Plus Ipilimumab.
Journal: Journal of clinical medicine
Published: February 07, 2023
Early primary renal tumor response predicts clinical outcome in patients with primary unresectable renal cell carcinoma with synchronous distant metastasis receiving molecularly targeted therapies.
Journal: Molecular and clinical oncology
Published: February 08, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026